Filing Details
- Accession Number:
- 0001209191-15-045416
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-21 16:51:47
- Reporting Period:
- 2014-04-09
- Filing Date:
- 2015-05-21
- Accepted Time:
- 2015-05-21 16:51:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1401667 | Puma Biotechnology Inc. | PBYI | Pharmaceutical Preparations (2834) | 770683487 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1553037 | Paul Richard Bryce | C/O Puma Biotechnology, Inc. 10880 Wilshire Blvd., Suite 2150 Los Angeles CA 90024 | Sr Vp, Clinical Research & Dev | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-04-09 | 2 | $87.35 | 2 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2014-04-11 | 28 | $82.49 | 30 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |